Neutralization activity of sera/IgG preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha, Beta, Gamma, Delta, and Kappa variants | Scientific Reports
PH records first B.1.617.1 COVID-19 variant case in Pampanga - YouTube
Overview of the SARS-CoV-2 genotypes circulating in Latin America during 2021 | bioRxiv
Rational Development of a Polysaccharide–Protein‐Conjugated Nanoparticle Vaccine Against SARS‐CoV‐2 Variants and Streptococcus pneumoniae - Deng - 2022 - Advanced Materials - Wiley Online Library
Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review - K - 2022 - Journal of Medical Virology - Wiley Online Library
List of SARS-CoV-2 variants of concern, variants of interest and variants for monitoring
Frontiers | Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
Frontiers | Tracking SARS-CoV-2 Variants Using a Rapid Typification Strategy: A Key Tool for Early Detection and Spread Investigation of Omicron in Argentina
Neutralization activity of sera/IgG preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha, Beta, Gamma, Delta, and Kappa variants | Scientific Reports
Neutralization activity of sera/IgG preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha, Beta, Gamma, Delta, and Kappa variants | Scientific Reports
SARS-CoV-2, strain hCoV-19/Italy/LAZ-INMI-642isl/2021, clade G, lineage B.1.617.1, VUM (former VOI Kappa) | EVAg
Neutralization activity of sera/IgG preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha, Beta, Gamma, Delta, and Kappa variants | Scientific Reports
Making Sense of Variants: They All Deserve Attention. A Few Merit Concern. - The Rockefeller Foundation